### Accession
PXD001000

### Title
CPTAC System Suitability (CompRef) Study: Phosphoproteome, PNNL

### Description
The objective of the "System Suitability (CompRef) Study" was to validate mass spectrometry protocols used at each Proteome Characterization Center (PCC).  Please include this attribution in publications, "Data used in this publication was created by the Clinical Proteomics Tumor Analysis Consortium (NCI/NIH)."

### Sample Protocol
Analytical Sample Protocol - Alkylation: Iodoacetamide, Enrichment: Fe3+ NTA-Agarose (Qiagen), Fractionation: Peptide basic pH Reversed Phase LC (pH 7.5), Fractions: 12, Labelling: 4-plex iTRAQ, Proteolysis: Trypsin, Starting Amount: 62 mg; Chromatography Protocol - Column Length: 70 cm, Column Type: C18, Gradient Length: 170 min, Injected: 0.5 ug, Inside Diameter: 50 um, Particle Size: 3 um, Particle Type: Phenomenex Jupiter C18; Mass Spectrometry Protocol - Collision Energy: 0.45, Dissociation: HCD, Instrument: Thermo LTQ Orbitrap Velos, MS1 Resolution: 30000, MS2 Resolution: 7500, Precursors: Top 10. See associated protocols and methods documents at https://cptac-data-portal.georgetown.edu.

### Data Protocol
Processed using the CPTAC Common Data Analysis Pipeline at NIST. Peptide identifications from MSGF+. Filtered at 1% FDR. See associated protocols and methods documents at https://cptac-data-portal.georgetown.edu.

### Publication Abstract
None

### Keywords
Cptac cptac-compref cptac-pnnl

### Affiliations
Georgetown University
Pacific Northwest National Laboratory

### Submitter
Nathan Edwards

### Lab Head
Dr Richard D. Smith, Ph.D.
Pacific Northwest National Laboratory


